video corpo

Cancer assay kit AmpFire®
for genotypingHPVfor PCR

Cancer assay kit - AmpFire® - Fujirebio - for genotyping / HPV / for PCR
Cancer assay kit - AmpFire® - Fujirebio - for genotyping / HPV / for PCR
Cancer assay kit - AmpFire® - Fujirebio - for genotyping / HPV / for PCR - image - 2
Add to favorites
Compare this product
 

Characteristics

Applications
for cancers, for genotyping
Micro-organism
HPV
Analysis mode
for PCR, isothermal nucleic acid amplification, for real-time PCR, fluorescence
Result display time

90 min

Sample volume

0.025 ml
(0.00085 US fl oz)

Description

Qualitative detection and identification of 15 High-Risk HPV genotypes 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, and 68. Fast. Simple. Accurate. Special Features: Method: -- Isothermal amplification with real time fluorescence detection Simplicity: -- Extremely simple sample processing - no DNA purification needed -- Limited hands-on time Fast: -- Sample-to-result in less than 1.5 hours* Accurate: -- High accuracy and sensitivity with all necessary controls Flexible: -- Suitable for different sample types -- Flexible sample numbers per run with no waste of reagents * depending on sample type. For FFPE samples: time to results approx. 160 minutes Details Technical Specifications: Sample types: Dry swab samples, Cervical samples stored in ThinPrep® (PreservCyt Solution), SurePathTM, FFPE biopsy, or purified DNA samples. Target region: Various regions in the viral genome including E6/E7 Equipment: ​​​​​​​Heating block and real-time PCR system (compatible with CFX96 - Bio-Rad, ABI7500 - Thermo Fisher Scientific, Rotor-Gene Q - QIAGEN, PowerGene 9600 - Atila PCR system, and other RT-PCR systems with 5 fluorescence channels)

Other Fujirebio products

Infectious Diseases

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.